DARPA invest in biotechnology
DARPA awarded CombiMatrix a contract to conduct basic research into their core technologies. See a press release here. The contract is worth up to $250 K. CombiMatrix works with molecules to develop detection systems for things like bio and chemical weapons. The technology also has commercial applications. DoD has put a lot of funding into a variety of technology to detect chemical and biological weapons beyond the current systems of swipe tests and sampling. This contract is just one small part of this effort and also illustrates how diverse the DoD Science and Technology (S&T) investment is.
